ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes.

Authors:
Dr Saurav Chatterjee, MD
Dr Saurav Chatterjee, MD
Mount Sinai St Luke's-Roosevelt Hospitals
Fellow
Cardiovascular Diseases
New York, New York | United States
Dr Sanjay Chatterjee, MD
Dr Sanjay Chatterjee, MD
Apollo Gleneagles Hospital
Consultant Diabetologist
Diabetology
Kolkata, West Bengal | India

Ann Intern Med 2013 Apr;158(8):JC8

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02008DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2013
58 Reads
17.810 Impact Factor

Publication Analysis

Top Keywords

dipeptidyl peptidase-4
4
review dipeptidyl
4
adverse events
4
peptidase-4 inhibitors
4
inhibitors increase
4
increase adverse
4
events type
4
type diabetes
4
acp journal
4
club review
4
journal club
4
type
1
events
1
diabetes
1
inhibitors
1
review
1
club
1
dipeptidyl
1
peptidase-4
1
increase
1

Similar Publications